EICHOR
● Recruiting
The Study of Ginkgo Leaf Dropping Pills and Huperzine a Injection Combined with Median Nerve Electrical Stimulation in the Treatment of Cognitive Impairment After Brain Injury
Condition: Cognitive Impairment After Brain Injury · Sponsor: Wanbangde Pharmaceutical Group Co., LTD
About this study
This study will conduct a single-center clinical trial to explore the initial therapeutic effect of ginkgo biloba dropping pills, huperzine A injection and median nerve electrical stimulation in patients with cognitive impairment.
This description comes directly from the study's public registry record.
Talk to the study team
Dong Wang · 18007076858 · 2623693068@qq.com
Always discuss trial participation with your own doctor first.
Locations (1)
| The Ganzhou City People's Hospital | Ganzhou, Jiangxi, China | Recruiting |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06704334